查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1967641

眼科PACS市场－全球产业规模、份额、趋势、机会、预测：按类型、运作模式、最终用途、地区和竞争格局划分，2021-2031年

Ophthalmology PACS Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Mode of Action, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球眼科 PACS 市场预计将从 2025 年的 1.4164 亿美元成长到 2031 年的 2.1078 亿美元，复合年增长率为 6.85%。

眼科影像存檔和通讯系统（OPCS）是专门开发的数位平台，用于在统一的介面中撷取、储存、搜寻和管理眼科诊断影像，例如眼底照片和光学同调断层扫描。这个市场的主要驱动因素包括：高患者量诊所迫切需要简化工作流程，以及全球眼科疾病盛行率不断上升，这需要强大的资料管理基础设施。正如国际防盲协会在2025年指出的那样，预计到2050年，全球视力丧失人口将达到18亿，这凸显了对可扩展诊断成像解决方案的迫切需求。

市场概览
预测期 2027-2031
市场规模：2025年 1.4164亿美元
市场规模：2031年 210,780,000 美元
复合年增长率：2026-2031年 6.85%
成长最快的细分市场 整合PACS
最大的市场 北美洲

市场成长的一大障碍是传统眼科设备之间互通性不足这一持续存在的挑战。这些设备通常采用专有资料格式，而非通用的DICOM标准。这种技术碎片化使得各种成像设备难以与中央资料库和电子健康记录集成，从而增加了实施成本。这些问题导致数据孤岛，阻碍了全面的患者照护，并给致力于维持高效协调的诊断环境的医疗机构带来了挑战。

市场驱动因素

眼科疾病和视力障碍的日益普遍是推动眼科影像归檔和通讯系统（PACS）普及应用的主要动力。医疗机构正努力应对快速增长的诊断数据，随着人口老化和糖尿病等慢性病的日益增多，诊所亟需强大的数位化归檔系统，以便高效储存和搜寻长期影像记录，从而实现有效的疾病监测。需要定期筛检的人群规模庞大，更凸显了这项需求。根据美国疾病管制与预防中心（CDC）2024年5月发布的《速览：视力丧失》报告，光是美国就有约9,300万成年人面临严重视力丧失的高风险，这需要可扩展的基础设施来处理相关的诊断工作量。

同时，人工智慧 (AI) 的整合应用正在推动市场变革，增强影像分析能力，使 PACS（影像存檔和通讯系统）从单纯的储存库转变为主动式诊断支援中心。现代平台越来越多地整合 AI 演算法，用于自动检测糖尿病视网膜病变等病变，从而减少人工评估时间和错误。 HCPLive 发布的《2024 年眼科年度回顾》（2024 年 12 月）报告了一项重大进展：美国 FDA核准了首款全自动、AI 驱动的携带式糖尿病视网膜病变筛检设备。 Topcon Healthcare 与微软于 2024 年建立策略合作伙伴关係，共同开发 AI 驱动的云端连结眼科健康解决方案，进一步推动了这项向智慧医疗的转变。

市场挑战

全球眼科PACS市场扩张的一大障碍是传统眼科设备之间持续存在的互通性不足问题。由于许多诊断设备采用专有资料格式而非普遍接受的DICOM标准，医疗机构面临严重的技术碎片化问题。这种碎片化环境阻碍了影像资料无缝传输至中央储存库，导致资料孤岛的形成，并扰乱了临床工作流程。无法轻鬆地跨系统聚合和存取影像显着降低了PACS解决方案的营运价值，使得医疗机构不愿投资或升级这些平台。

这种技术上的不相容性直接阻碍了市场推广，增加了实施成本和管理负担，因为医疗机构更倾向于能够轻鬆整合到现有基础设施中的解决方案。对连接性的需求非常高；根据美国医学会 (AMA) 2024 年的一项调查，84% 的医生认为有效的电子健康记录 (EHR) 整合是采用新型数位医疗技术的先决条件。目前缺乏强大的互通性导致眼科诊所不愿扩展其数位成像能力，从而延缓了整体市场收入潜力和地域覆盖范围的扩大。

市场趋势

向基于云端和SaaS的部署模式的转变正在革新全球眼科PACS市场，使其能够突破诊所的物理限制，实现可扩展的数据集中化。随着医疗服务提供者整合来自多个地点的诊断影像数据，云端架构能够柔软性管理大量资料集，而无需大规模的本地IT投资。这一趋势在高频筛检平台的部署中尤其明显。根据拓普康医疗（Topcon Healthcare）2025年7月发布的新闻稿《拓普康医疗收购智能视网膜成像系统》（Topcon Healthcare Acquisitions Intelligent Retinal Imaging Systems），该公司基于云的视网膜筛检技术已完成超过180万次检查，并识别出超过27.9万个糖尿病病变，这充分展现了研究能力。

同时，远距眼科和远距医疗能力的扩展正在改变患者管理策略，尤其是在慢性病监测方面。为了优化专家资源，诊所正在验证混合医疗模式，即远端进行影像检查，并透过PACS系统非同步解读。这些工作流程已被证明是传统评估方法的可靠替代方案。例如，2025年4月在美国眼科学会（ARVO）上发表的一篇题为「混合远端医疗模式在青光眼管理中的有效性」的摘要显示，约95%的混合远端医疗会诊得出的观察和治疗方案与面对面会诊的结果和方案一致。这凸显了推动远距离诊断服务普及的可靠性。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球眼科PACS市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型（独立PACS、整合式PACS）
    • 依运作模式（本机部署系统、云端系统）
    • 依最终用户（医院、专科诊所等）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美眼科PACS市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲眼科PACS市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区眼科PACS市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲眼科PACS市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲眼科PACS市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球眼科PACS市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Carl Zeiss Meditec AG
  • Topcon Corp
  • Heidelberg Engineering GmbH
  • Sonomed Escalon
  • Visbion Ltd
  • Eyepacs LLC
  • VersaSuite
  • Merge Healthcare Inc
  • ScImage Inc

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 21824

The Global Ophthalmology PACS Market is projected to expand from USD 141.64 Million in 2025 to USD 210.78 Million by 2031, reflecting a compound annual growth rate of 6.85%. Ophthalmology Picture Archiving and Communication Systems are specialized digital platforms developed to acquire, store, retrieve, and manage ophthalmic diagnostic images, such as fundus photographs and optical coherence tomography scans, within a unified interface. The primary factors driving this market include the urgent need for improved workflow efficiency in high-volume clinics and the increasing global prevalence of eye diseases, which demands robust data management infrastructures. As noted by the International Agency for the Prevention of Blindness in 2025, the number of individuals globally affected by vision loss is expected to reach 1.8 billion by 2050, highlighting a critical need for scalable imaging solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 141.64 MIllion
Market Size 2031USD 210.78 MIllion
CAGR 2026-20316.85%
Fastest Growing Segmentintegrated PACS
Largest MarketNorth America

A significant barrier to market growth is the ongoing challenge of limited interoperability among legacy ophthalmic devices, which often rely on proprietary data formats instead of the universal DICOM standard. This technical fragmentation makes it difficult to integrate various imaging modalities with central repositories and Electronic Medical Records, leading to increased implementation costs. Consequently, these issues create data silos that obstruct comprehensive patient care, posing a challenge for healthcare providers attempting to maintain efficient and connected diagnostic environments.

Market Driver

The increasing prevalence of ophthalmic disorders and vision impairment serves as a major catalyst for the adoption of Ophthalmology PACS, as healthcare providers struggle to manage rapidly growing volumes of diagnostic data. With aging populations and the rise of chronic conditions like diabetes, clinics require robust digital archiving systems to efficiently store and retrieve longitudinal imaging records for effective disease monitoring. This demand is highlighted by the scale of the population requiring regular screening; according to the Centers for Disease Control and Prevention's 'Fast Facts: Vision Loss' report from May 2024, approximately 93 million adults in the United States alone are at high risk for serious vision loss, necessitating scalable infrastructure to handle the associated diagnostic workload.

Concurrently, the integration of Artificial Intelligence for enhanced image analysis is driving market evolution by transforming PACS from simple storage repositories into active diagnostic support hubs. Modern platforms are increasingly embedding AI algorithms to automatically detect pathologies such as diabetic retinopathy, thereby reducing manual grading time and errors. A significant advancement was noted by HCPLive in 'Ophthalmology Year in Review: 2024' (December 2024), reporting that the U.S. FDA cleared the first fully autonomous AI for portable diabetic retinopathy screening. This shift toward intelligent care is further evidenced by Topcon Healthcare's 2024 strategic partnership with Microsoft to develop AI-powered, cloud-connected ocular health solutions.

Market Challenge

A substantial barrier to the expansion of the Global Ophthalmology PACS Market is the persistent issue of limited interoperability among legacy ophthalmic devices. Since many diagnostic instruments utilize proprietary data formats rather than the universal DICOM standard, healthcare providers encounter severe technical fragmentation. This disjointed ecosystem prevents the seamless transfer of imaging data into centralized repositories, resulting in isolated data silos that disrupt clinical workflows. When images cannot be easily aggregated or accessed across different systems, the operational value of a PACS solution is significantly reduced, discouraging healthcare facilities from investing in or upgrading these platforms.

This technical incompatibility directly stifles market adoption by inflating implementation costs and administrative burdens, as healthcare organizations prefer solutions that integrate effortlessly with existing infrastructures. The demand for connectivity is substantial; according to the American Medical Association in 2024, 84% of physicians identified effective Electronic Health Record integration as a mandatory requirement for adopting new digital health technologies. Without robust interoperability, ophthalmology clinics remain hesitant to scale their digital imaging capabilities, thereby slowing the market's overall revenue potential and geographic reach.

Market Trends

The shift toward Cloud-Based and SaaS Deployment Models is revolutionizing the Global Ophthalmology PACS Market by facilitating scalable data centralization beyond the physical confines of clinics. As healthcare providers integrate diagnostic imaging from various locations, cloud architectures offer the flexibility required to manage massive datasets without significant on-premise IT investments. This trend is particularly visible in the adoption of platforms built for high-volume screening. According to a July 2025 press release from Topcon Healthcare titled 'Topcon Healthcare Acquires Intelligent Retinal Imaging Systems,' their cloud-based retinal screening technology has enabled over 1.8 million screenings and identified more than 279,000 cases of diabetic pathology, proving the capacity of cloud solutions to support large-scale diagnostic networks.

Simultaneously, the expansion of Tele-ophthalmology and Remote Care Capabilities is altering patient management strategies, especially for monitoring chronic conditions. Driven by the need to optimize specialist availability, clinics are increasingly validating hybrid care models where imaging is performed remotely and reviewed asynchronously via PACS integration. These workflows are proving to be clinically reliable alternatives to traditional assessments. For instance, an April 2025 abstract from the Association for Research in Vision and Ophthalmology titled 'Effectiveness of a hybrid telemedicine model in glaucoma management' revealed that approximately 95% of hybrid telemedicine visits resulted in findings and management plans consistent with in-person visits, underscoring the reliability driving the adoption of remote diagnostic services.

Key Market Players

  • Carl Zeiss Meditec AG
  • Topcon Corp
  • Heidelberg Engineering GmbH
  • Sonomed Escalon
  • Visbion Ltd
  • Eyepacs LLC
  • VersaSuite
  • Merge Healthcare Inc
  • ScImage Inc

Report Scope

In this report, the Global Ophthalmology PACS Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ophthalmology PACS Market, By Type

  • Standalone PACS
  • Integrated PACS

Ophthalmology PACS Market, By Mode of Action

  • On-premise system
  • Cloud-based system

Ophthalmology PACS Market, By End-use

  • Hospitals
  • Specialty clinics
  • Others

Ophthalmology PACS Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ophthalmology PACS Market.

Available Customizations:

Global Ophthalmology PACS Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ophthalmology PACS Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Standalone PACS, Integrated PACS)
    • 5.2.2. By Mode of Action (On-premise system, Cloud-based system)
    • 5.2.3. By End-use (Hospitals, Specialty clinics, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Ophthalmology PACS Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Mode of Action
    • 6.2.3. By End-use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Ophthalmology PACS Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Mode of Action
        • 6.3.1.2.3. By End-use
    • 6.3.2. Canada Ophthalmology PACS Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Mode of Action
        • 6.3.2.2.3. By End-use
    • 6.3.3. Mexico Ophthalmology PACS Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Mode of Action
        • 6.3.3.2.3. By End-use

7. Europe Ophthalmology PACS Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Mode of Action
    • 7.2.3. By End-use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Ophthalmology PACS Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Mode of Action
        • 7.3.1.2.3. By End-use
    • 7.3.2. France Ophthalmology PACS Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Mode of Action
        • 7.3.2.2.3. By End-use
    • 7.3.3. United Kingdom Ophthalmology PACS Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Mode of Action
        • 7.3.3.2.3. By End-use
    • 7.3.4. Italy Ophthalmology PACS Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Mode of Action
        • 7.3.4.2.3. By End-use
    • 7.3.5. Spain Ophthalmology PACS Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Mode of Action
        • 7.3.5.2.3. By End-use

8. Asia Pacific Ophthalmology PACS Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Mode of Action
    • 8.2.3. By End-use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Ophthalmology PACS Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Mode of Action
        • 8.3.1.2.3. By End-use
    • 8.3.2. India Ophthalmology PACS Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Mode of Action
        • 8.3.2.2.3. By End-use
    • 8.3.3. Japan Ophthalmology PACS Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Mode of Action
        • 8.3.3.2.3. By End-use
    • 8.3.4. South Korea Ophthalmology PACS Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Mode of Action
        • 8.3.4.2.3. By End-use
    • 8.3.5. Australia Ophthalmology PACS Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Mode of Action
        • 8.3.5.2.3. By End-use

9. Middle East & Africa Ophthalmology PACS Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Mode of Action
    • 9.2.3. By End-use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Ophthalmology PACS Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Mode of Action
        • 9.3.1.2.3. By End-use
    • 9.3.2. UAE Ophthalmology PACS Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Mode of Action
        • 9.3.2.2.3. By End-use
    • 9.3.3. South Africa Ophthalmology PACS Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Mode of Action
        • 9.3.3.2.3. By End-use

10. South America Ophthalmology PACS Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Mode of Action
    • 10.2.3. By End-use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Ophthalmology PACS Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Mode of Action
        • 10.3.1.2.3. By End-use
    • 10.3.2. Colombia Ophthalmology PACS Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Mode of Action
        • 10.3.2.2.3. By End-use
    • 10.3.3. Argentina Ophthalmology PACS Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Mode of Action
        • 10.3.3.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Ophthalmology PACS Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Carl Zeiss Meditec AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Topcon Corp
  • 15.3. Heidelberg Engineering GmbH
  • 15.4. Sonomed Escalon
  • 15.5. Visbion Ltd
  • 15.6. Eyepacs LLC
  • 15.7. VersaSuite
  • 15.8. Merge Healthcare Inc
  • 15.9. ScImage Inc

16. Strategic Recommendations

17. About Us & Disclaimer